Sun Valley: Canagold’s Continued Arrogance and Excuses Will Not Fix Share Price
08 July 2022 - 11:16PM
Business Wire
Institutional Shareholder Services Inc., the
world’s leading provider of corporate governance and responsible
investment solutions and independent proxy advisor, recommends
Canagold shareholders vote FOR change on Sun Valley’s BLUE proxy
card
Sunvalley Company DMCC (“Sun Valley”), a strategic and
long-term focused investor owning 17.6% of Canagold Resources Ltd
(TSX: CCM) (“Canagold” or the “Company”), releases
the following statement from Vikram Sodhi, Managing Director and
Co-Founder of Sun Valley:
“Bradford Cooke and the board of directors of Canagold (the
“Board”) are at it again. Another day, another missive of
excuses for Mr. Cooke’s inability or unwillingness to comply with
basic securities laws and a plummeting share price.
The members of this Board are either too arrogant to admit they
have made mistakes or simply do not care about your failing
investment. (And why would they, the independent directors lumped
together only own 1.17% of the Company.)
Since their excuses haven’t changed and shareholders are still
left without answers, it is important to remind you of the facts
and once again ask the Board to provide legitimate answers.
Had Sun Valley not taken up this campaign for change, the
following would never have come to light:
- If you invested $100 in Canagold when it was listed on TSX,
you would have less than $2
today.
- At the same time as there has been a 98% in value destruction,
Mr. Cooke was rewarded with over $2.6 million
in cash.
- Directors have given themselves a 1,127%
increase in the value of directors fees last year. Now, they
are looking to reload their stock option plan and dilute
shareholders by 20%. In the recommendation given by Institutional
Shareholder Services Inc. (“ISS”), among other negative points, ISS
states the proposed plan as having Excessive Plan Cost, Excessive
Dilution and Excessive Burn Rate.
- Mr. Cooke sold shares ahead of the press release announcing a
major private placement, then bought shares at a deeply discounted
price, reducing his cost by $123,000. In late 2020, he obtained
shares representing approximately 3.5% of the Company at prices up
to a 40% discount to market at the time closing, most of this
purchase he only filed on SEDI last month. It is not at all clear
where he got these shares from and he is giving no explanation to
shareholders. And this is but one example of
his highly unusual trading and poor governance.
- There is no credible rationale for why New Polaris has not
advanced in 28 years. Management excuse is that the ore is
refractory and therefore the project couldn’t advance until they
“discovered” BIOX. But while Canagold management did nothing,
approximately 20 other projects built processing plants for
refractory ore, most of them using BIOX. ISS point this out: “it
seems inappropriate to write off the majority of the company's
history, the decline in share value as a result of multiple decades
of financings, and the speed at which it has been able to advance
its core asset as being due to a case [of] technology needing to
catch up to asset complexity” Then ISS points out what we have been
saying and trying to achieve: “a board comprised of the three
dissident nominees could deliver shareholder value by completing an
appropriately sized capital raise, a feasibility study, and
advancing the permitting process of New Polaris so that a mine may
be built – things that have not occurred under the stewardship
of the current board during the company's entire existence.”
“The dissident slate, and strategic plan by extension, introduce a
credible potential financing option to fund a feasibility study, a
proposed timetable that can serve to enhance the accountability of
the board and management”
Sick of the arrogance of Mr. Cooke and the current Board and the
notion that the rules should not apply to them and that your
invested money is theirs?
We are too.
It’s time for a change.
Do what ISS, the world's leading provider of corporate
governance and responsible investment solutions and independent
proxy advisor recommends – vote ONLY on the BLUE
proxy form. Many of your fellow shareholders have already voted
their BLUE proxy. Click here to add your vote to the growing
list of shareholders who are sick of seeing their investment go
down the drain and want a new accountable Board.
Vikram Sodhi, Sun Valley 17.6% Shareholder
PS – Shareholders have asked why the Board has zeroed in on our
one office in Dubai and me personally. We wonder too. If you want
the real facts call 1-888-213-0093.”
DO NOT WAIT: VOTE THE BLUE PROXY
NOW
Time is running out. Only your vote can save your
investment. Shareholders are encouraged to vote only the
BLUE proxy FOR all three of Sun Valley’s
highly-experienced, independent nominees – Dr. Carmen Letton, Ms.
Sofia Bianchi and Mr. Andrew Trow.
Don’t wait, voting is fast and easy. Please vote well in
advance of the proxy voting deadline of Thursday, July 14, 2022 at
5:00 p.m. ET. If you have questions or need help voting, contact
Kingsdale Advisors at 1-888-213-0093 or at
contactus@kingsdaleadvisors.com.
Advisors
Kingsdale Advisors is acting as strategic shareholder and
communications advisor to Sun Valley. McMillan LLP, Wildeboer
Dellelce LLP and Crawley Mackewn Brush LLP are acting as legal
counsel to Sun Valley.
About Sun Valley
Sun Valley is a private equity firm focussed on the precious
metals industry with portfolio companies and branch offices in the
Americas, Europe and Asia. Sun Valley seeks to invest in
sustainable development projects and operations with growth
potential, low cash costs of production, or the operating
flexibility to insulate against volatility in the commodity
markets.
Cautionary Statement Regarding Forward-Looking
Statements
This press release contains forward-looking information within
the meaning of applicable securities laws. In general,
forward-looking information refers to disclosure about future
conditions, courses of action, and events. All statements contained
in this press release that are not clearly historical in nature or
that necessarily depend on future events are forward-looking, and
the use of any of the words “anticipates”, “believes”, “expects”,
“intends”, “plans”, “will”, “would”, and similar expressions are
intended to identify forward-looking statements. These statements
are based on current expectations of Sun Valley and currently
available information. Forward-looking statements are not
guarantees of future performance, involve certain risks and
uncertainties that are difficult to predict, and are based upon
assumptions as to future events that may not prove to be accurate.
Sun Valley undertakes no obligation to update publicly or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise, except as required by
applicable securities legislation.
Disclaimer
The information contained or referenced herein is for
information purposes only in order to provide the views of Sun
Valley and the matters which Sun Valley believes to be of concern
to shareholders described herein. The information is not tailored
to specific investment objectives, the financial situations,
suitability, or particular need of any specific person(s) who may
receive the information, and should not be taken as advice in
considering the merits of any investment decision. The views
expressed herein represent the views and opinions of Sun Valley,
whose opinions may change at any time and which are based on
analyses of Sun Valley and its advisors.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220708005270/en/
Sun Valley: Daniel Henao Partner / VP Business Development
Phone: 6042607046 Email: dhenao@sunvalleyinv.com
Kingsdale Advisors: Tom Graham Executive Vice President, Western
Canada Direct: 587-330-1924 Email:
tgraham@kingsdaleadvisors.com
Media: Hyunjoo Kim Vice President, Strategic Communications and
Marketing Direct: 416-867-2357 Email:
hkim@kingsdaleadvisors.com
Concord Medical Services (NYSE:CCM)
Historical Stock Chart
From Jan 2025 to Feb 2025
Concord Medical Services (NYSE:CCM)
Historical Stock Chart
From Feb 2024 to Feb 2025